OPtimal stEnt Deployment stRategy oF Contemporary sTents - Registry to Evaluate Percutaneous Coronary Intervention Using Bioresorbable Scaffolds With Thinner-strut Construction and Guidance by intracOronary Imaging to REduce Scaffold Failure

Exclusion Criteria

• •1. Culprit lesions in the setting of acute coronary syndrome.
• •2. Lesions with severe calcification.
• •3. Lesions in a coronary artery with severe tortuosity.
• •4. Left main coronary artery lesions.
• •5. Bifurcation lesions.
• •6. Ostial lesions.
• •7. Lesions with a difference in proximal and distal reference diameter of \>0.5 mm by visual judgement of the coronary angiogram by the treating operator.
• •8. Treatment of in-stent restenosis or stent thrombosis.
• •9. History of definite stent thrombosis.
• •10. Lesions in coronary artery bypass grafts.
• •11. Lesions not suitable for OCT or IVUS catheter delivery and imaging, e.g. due to tortuosity or distal localisation.
• •12. Creatinine Clearance ≤ 30 ml/min/1.73 m2 as calculated by MDRD formula for estimated GFR.
• •13. Contraindication to dual antiplatelet therapy with aspirin and a P2Y12 inhibitor or (if indicated) NOAC and P2Y12 inhibitor.
• •14. Planned non-deferrable major surgery after PCI.
• •15. Known comorbidity associated with a life expectancy \<1 year.
• •16. Unable to understand and follow study-related instructions or unable to comply with study protocol.